--- a
+++ b/clusters/3009knumclusters/clust_73.txt
@@ -0,0 +1,833 @@
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL, within 2 weeks of randomization
+Must be obtained within 14 days prior to registration for protocol therapy: Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Within 14 days of treatment initiation: Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+NOTE: Patients with documented bone marrow involvement by lymphoma are not required to meet the above hematologic parameters, but must have a platelet count of at least 75,000/mcL and neutrophil count of at least 1,000/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcl obtained within 28 days prior to sub-study registration
+Absolute neutrophil count (ANC) >= 1,500/mcL within 14 days prior to step 2 randomization
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL within 28 days prior to registration
+Absolute neutrophil count (ANC) >= 1,000/mcL; must be obtained within 28 days prior to registration
+Absolute neutrophil count (ANC) >= 1,500 microliter (mcL), obtained within 28 days prior to step 2 registration
+Within 14 days prior to registration: Absolute neutrophil count (ANC) >= 1,500/mcl
+Absolute neutrophil count (ANC) >= 1,500/mcl
+Absolute neutrophil count (ANC) >= 1,500/mcL within 28 days prior to registration
+Absolute neutrophil count >= 1,500/mcL within 4 weeks before randomization
+Obtained within 28 days prior to registration: Absolute neutrophil count (ANC) >= 1,500/mcl
+Absolute neutrophil count (ANC) >= 1,500/mcl
+Absolute neutrophil count (ANC) >= 1,500 microliter (mcL)
+Absolute neutrophil count (ANC) >= 1,500/mcl documented within 28 days prior to step 1 registration
+Absolute neutrophil count (ANC) >= 750/mcl within 28 days prior to registration
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL (unless documented bone marrow involvement with lymphoma)
+absolute neutrophil count (ANC) ?1,500/mcL
+Absolute neutrophil count > 1,500/mcl
+Within 21 days of treatment initiation:\r\nAbsolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count greater than or equal to 1,500/mcl
+Absolute neutrophil count >= 1,500/mcL
+Measured within 28 days prior to registration: absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Within 14 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL (up to 14 days before treatment initiation)
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Within 14 days of treatment initiation:\r\nAbsolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Within 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,000 /mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count ? 1,500/mcL within 14 days of registration
+Absolute neutrophil count (ANC) >= 1500/mcL, performed within 10 days of treatment initiation
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL, performed within 14 days of treatment initiation
+Absolute neutrophil count >= 1,000/mcL
+SAFETY RUN-IN: Within 10 days of registration: Absolute neutrophil count (ANC) >= 1,500 /mcL
+RANDOMIZED PHASE II CLINICAL TRIAL: Within 10 days of registration: Absolute neutrophil count (ANC) >= 1,500 /mcL
+Within 30 days prior to enrollment: Absolute neutrophil count greater than or equal to 1,500/mcl
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count ? 1,200/mcl
+Absolute neutrophil count >= 1,500/mcL (>= 1,500/mm^3)
+Absolute neutrophil count > 1500 cells/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcl
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 750/mcL (documented within 28 days of registration)
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+PIK3CA WILD TYPE COHORT (closed 03/17/2016): Absolute neutrophil count >= 1,500/mcL
+ENDOCRINE RESISTANT AND ADJUVANT COHORT: Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) < 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL.
+Absolute neutrophil count > 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count ? 1,500/mcL
+Absolute neutrophil count ? 1,500 /mcl
+Absolute neutrophil count >= 1,500/mcL
+Obtained within 21 days prior to study registration: absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL.
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+EXPANDED ACCESS COHORT: Absolute neutrophil count >= 1,000/mcL
+Absolute lymphocyte count > 500/ mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL, performed within 10 days of treatment initiation
+Within 14 days of treatment registration: Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1.5 K/mcL
+Absolute neutrophil count >= 1,500/mcl
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Within 2 weeks prior to initiation of study treatment: Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) > 1000/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 14 days of treatment initiation
+Absolute neutrophil count (ANC) >= 1,500 /mcL within 14 days of treatment initiation
+Absolute neutrophil count > 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,000/mcL (performed within 28 days of treatment initiation)
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 28 days of study registration
+Absolute neutrophil count (ANC): >= 1500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count ?1,500/mcL
+COHORT I: Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 750/mcL; a subject will not be excluded because of pancytopenia related to disease
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count > 1,000/mcL
+Absolute neutrophil count >= 1,500/mcl
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute granulocyte count >= 1,500/mcL, within 16 days of starting therapy
+Absolute lymphocyte count >= 500/mcL, within 16 days of starting therapy
+Absolute neutrophil count ? 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL.
+Absolute neutrophil count >= 1,500/mcL without growth factor support, =< 5 days prior to C1D1
+Absolute neutrophil count >= 1,500/mcL.
+Absolute neutrophil count ? 1000/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 28 days of treatment initiation
+Performed within 10 days of treatment initiation: Absolute neutrophil count (ANC) ? 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL, should be performed within 10 days of treatment initiation
+Absolute neutrophil count >= 1,500/mcl
+Absolute neutrophil count at least 1,200/mcL
+Neutrophil count of more than or equal to 1.0 x 10^9 cells/mcL
+Absolute neutrophil count > 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 10 days of treatment
+Absolute neutrophil count >= 1,500/mcL.
+Absolute neutrophil count (ANC) ? 1,500 /mcL within 21 days of treatment initiation
+Absolute neutrophil count ? 1,000/mcL
+Absolute neutrophil count (ANC) >= 1,000/mcL within 21 days of treatment initiation
+Performed within 10 days of treatment initiation: absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count < 1,500/mcL
+Should be performed within 30 days of treatment initiation: absolute neutrophil count (ANC) ? 1,000 /mcL
+Absolute neutrophil count (ANC) >= 1,500 microliter (mcL)
+Within 28 days of cycle 1 day 1: Absolute neutrophil count (ANC)\t>= 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL (performed within 10 days of treatment initiation)
+Within 5 days prior to the start of study treatment: Absolute neutrophil count (ANC) >= 1,500 /mcL.
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count ? 500/mcL, and have not received any growth factor support for at least 4 weeks prior to screening
+Within 28 days prior to administration of study treatment: Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count > 1000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Within two weeks prior to enrollment: Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 14 days of treatment initiation
+Absolute neutrophil count (ANC) >= 1,500/mcL, performed within 28 days of treatment initiation
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL.
+Absolute neutrophil count >= 1,000/mcL
+To be performed within 14 days of treatment initiation: absolute neutrophil count (ANC) ? 1,500 /mcL
+Absolute neutrophil count (ANC) ? 1,000 /mcL within 14 days of treatment initiation
+Absolute neutrophil count >= 1,500/mcL within 14 days of treatment initiation
+Within 10 days of treatment initiation: Absolute neutrophil count >= 1500/mcL.
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL.
+Within 14 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1.5 k/mcl, obtained within 7 days prior to first study treatment
+Performed within 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1000/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL.
+Within 7 days of registration: Absolute neutrophil count (ANC) >= 1,500/mcL
+Within 14 days of the first dose of the study drugs: Absolute neutrophil count >= 1000/mcL.
+Within 10 days prior to on-study date: Absolute neutrophil count (ANC) ? 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count >= 750/mcL; >= 500/mcL if impairment is due to LPD/NHL
+Absolute neutrophil count (ANC) >= 750 /mcL
+Obtained within 21 days of registration: absolute neutrophil count (ANC) > 1,500/mcL
+Within 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Within 10 days of treatment initiation: Absolute neutrophil count (ANC) ? 1,500/mcL
+Absolute neutrophil count (ANC) ? 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL (without transfusion or cytokine support)
+Absolute lymphocyte count >= 800/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL (performed within 10 days of treatment initiation)
+Absolute neutrophil count >= 1,500/mcL
+Performed within 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500 /mcL
+CHEMOTHERAPY/CELL INFUSION ELIGIBILITY: Absolute neutrophil count greater than or equal to 1000/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count (ANC) >= 1,500/ mcL
+Absolute neutrophil count (ANC) >= 1,000 /mcL, performed within 10 days of treatment initiation
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Performed within 7 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL within 30 days of registration
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL 14 days or fewer from registration
+Absolute neutrophil count (ANC) >= 1,000 /mcL
+Absolute neutrophil count (ANC) >= 1,000/mcL, performed within 14 days of treatment initiation
+Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 10 days of treatment initiation
+Absolute neutrophil count >= 1,200/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count >= 1,000/mcL
+Obtained within 14 days prior to enrollment: absolute neutrophil count (ANC) >= 1,000/mcL
+Absolute neutrophil count (ANC) >= 1500/mcL, performed within 14 days of protocol registration
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) > 1000/mcL
+Absolute neutrophil count >= 1,000/mcL
+Performed within 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL within 14 days of treatment initiation
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil >= 1,000/mcL; transfusion and/or growth factor are permitted within any timeframe
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count >= 1,000/mcL
+Within 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500/mcL
+Within 14 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count (ANC) >/=1000 cells per microliter (cells/mcL) (Cohorts A, B, D, E, F)
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL, performed within 14 days of registration
+Bone marrow reserve consistent with absolute neutrophil count (ANC) >= 1500 per micro liter (/mcL); platelet count >= 100,000/mcL; hemoglobin A1c (HbA1c) less than (<) 6.5 percent (%).
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Performed within 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL, assessed within 14 days prior to registration
+Absolute neutrophil count >= 1,000/mcL (without growth factor support)
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,000/mcL
+Absolute neutrophil count >= 500/mcL (in the absence of growth factor support), within 14 days prior to treatment
+Absolute neutrophil count >= 1500 mcL
+Absolute neutrophil count (ANC) >= 500 /mcL performed within 10 days of treatment initiation
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL.
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count (ANC) >=1,500 /mcL (within 10-15 days of treatment initiation)
+Absolute neutrophil count (ANC) >= 1,000/mcL
+Absolute neutrophil count (ANC) >= 1,000/mcL within 16 days of treatment initiation
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL, during screening and on cycle 1, day 1
+Absolute neutrophil count (ANC) >= 1,500/mcL within 14 days of treatment initiation
+ANC ?1500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,000 /mcL (performed within 10 days of treatment initiation)
+Absolute neutrophil count (ANC) >= 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL, regardless of transfusion or growth factor support
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,000/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Within 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+PHASE II: Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC): >= 1,500 /mcL
+Absolute neutrophil count >= 1,500/mcL
+Completed within 10 days of SBRT treatment initiation: Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL within 14 days of treatment initiation
+Absolute neutrophil count >= 750/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL within 14 days prior to registration
+Absolute neutrophil count >= 1,500/mcL
+Within 14 days prior to registration: Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) > 500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,200/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL, obtained within 14 days of first dose of drug
+PHASE I: Absolute neutrophil count >= 1,500/mcL without growth factor support
+PHASE II SCLC: Absolute neutrophil count >= 1,500/mcL without growth factor support
+UROTHELIAL CARCINOMA EXPANSION COHORT: Absolute neutrophil count >= 1,500/mcL without growth factor support
+mCRPC EXPANSION COHORT: Absolute neutrophil count >= 1,500/mcL without growth factor support
+Absolute neutrophil count (ANC) >= 1,000 /mcL, performed within 10 days of treatment initiation
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count >= 1,000/mcl
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,000/mcL
+Absolute neutrophil count (ANC) >= 1,000/mcL with no growth factor support in the previous 3 weeks
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count >= 1,500/mcL
+Performed 28 days prior to study registration up to the first dose of study drug: absolute neutrophil count (ANC) >= 1,000 /mcL
+Within 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1500/mcL
+Absolute neutrophil count >= 1,000/mcl
+Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 10 days of treatment initiation
+Absolute neutrophil count >= 1,500/mcl
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count (ANC) >= 1500/mcL (within 28 days of treatment initiation)
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Performed within 14 days (+3 working days) of treatment initiation: Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count (ANC) >= 1,000/mcL
+Absolute neutrophil count: >= 1,000/mcl
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count >= 750/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcl
+Absolute neutrophil count >= 1,500/mcL
+Performed within 14 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,000/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count (ANC) < 1000/mcl
+Absolute neutrophil count >= 1,500/mcl
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+PHASE I: Absolute neutrophil count (ANC) > 1,500/mcl
+PHASE II: Absolute neutrophil count (ANC) > 1,500/mcl
+Absolute neutrophil count >= 1,000/mcL.
+Absolute neutrophil count (ANC) >= 1,500/mcL except in cases of marrow infiltration by lymphoma
+Within 14 days of first dose of study drug administration: Absolute neutrophil count >= 1,500/mcL (1.5 x 10^9/L)
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count < 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Lymphocyte count > 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,000/mcL
+Patients with adequate organ function, reflected by the following parameters: WBC ? 3000/mcl Absolute neutrophil count (ANC) ? 1500/mcl Platelet count ? 100,000/mcl SGOT, SGPT, and alkaline phosphatase ? 2.5 X upper limit of normal (ULN) Bilirubin ? 1.5 X ULN Creatinine ? institutional ULN
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count > 500 mcL
+Absolute neutrophil count >= 1,500/mcL
+Performed within 28 days prior to study registration up to the first dose of study drug: Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL, performed within 10 days of treatment initiation
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcl
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Performed within 10 days of treatment initiation; absolute neutrophil count (ANC) ? 1,500 /mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL, determined within 14 days of registration
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,250/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,200/mcL (without growth factor support)
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcl
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcl
+Absolute neutrophil count >= 1,200/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count (ANC) >= 1,200/mcL (subjects may be treated with hematopoietic growth factors to achieve or maintain this level)
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count > 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count > 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1500/mcL (1.5 x 10^9/L) obtained within 2 weeks prior to registration
+Absolute neutrophil count >= 1,500/mcL
+Newly diagnosed MCL: Absolute neutrophil count (ANC) > 750/mm^3; patients who have bone marrow infiltration by MCL are eligible if their ANC is equal to or > than 500
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) < 1000/mcL
+Absolute neutrophil count (ANC) >= 1 K/mcL, with or without filgrastim (GCSF) support
+Absolute neutrophil count >= 1,500/mcL
+Patients must have absolute neutrophil count (ANC) > 1000/mcl
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count >= 1.0 K/mcL, without use of growth factor support for 1 week
+Within 4 weeks of preregistration: Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1.5 K/mcL
+Absolute lymphocyte count >= 500/mcl
+Absolute neutrophil count >= 500/mcl
+Absolute neutrophil count (ANC) ? 1,000/mcL OR ? 750/mcL if neutropenia due to iBCL
+Absolute neutrophil count (ANC) >= 1,500/mcL, should be performed within 10 days of treatment initiation
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >1,500/mcL
+Absolute neutrophil count ? 1,000/mcL
+Within 14 days prior to registration: Absolute neutrophil count (ANC) >= 1,500/mcl
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+REGISTRATION TO TREATMENT (STEP 1): Absolute neutrophil count (ANC) >= 1,500 /mcL, within 14 days prior to first dose of pembrolizumab
+REGISTRATION TO TREATMENT (STEP 2): Absolute neutrophil count (ANC) >= 1,500 /mcL, within 14 days prior to first dose of pembrolizumab
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcl
+Absolute neutrophil count (ANC) >= 1500 /mcL
+Absolute neutrophil count (ANC) ? 1000 /mcL within 7 days of treatment initiation
+All screening labs should be performed within 14 days (+3 working days) of treatment initiation: absolute neutrophil count (ANC) >= 1,500 /mcL;
+Absolute neutrophil count (ANC) ? 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 28 days of treatment initiation
+Within 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcl
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL (patients may be treated with hematopoietic growth factors to achieve or maintain this level)
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count (ANC) >= 1,000/mcL without growth factors within 2 week of initiation of treatment
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL (performed within 10 days of treatment initiation)
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count > 1,500/mcL
+TUMOR BIOPSY SEQUENCING: Absolute neutrophil count >= 1,000/uL (mcL)
+TREATMENT: Absolute neutrophil count >= 1,000/uL (mcL)
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+DOSE ESCALATION COHORT: Absolute neutrophil count ? 1,500/mcL
+DOSE EXPANSION COHORT: Absolute neutrophil count ? 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1500/mcL
+Within 28 days prior to administration of therapy: Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >=1,500 /mcL
+Absolute neutrophil count (ANC) >= 1,500/mcl
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL without the use of hematopoietic growth factors
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL, OR >= 1,000/mcL if lymphomatous bone marrow involvement, performed within 10 days of treatment initiation
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count > 1,200/mcL
+Step 2: Absolute neutrophil count > 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute lymphocyte count >= 800/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Within 14 days of registration: Absolute neutrophil count (ANC) >= 1,000/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 750 cells/mcL (0.75 x 10^9/L)
+Within 30 days prior to treatment initiation: Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcl obtained within 28 days prior to Step 2 re-registration
+Absolute lymphocytes count >= 500/mcL
+Absolute neutrophil count >= 1,000/mcL (without hematopoietic growth factors)
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,000/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcl obtained within 28 days prior to Step 2 re-registration
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcl obtained within 28 days prior to step 2 re-registration
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+PHASE II: Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcl
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcl
+Absolute neutrophil count >= 1,200/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcl
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count greater than or equal to 1000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,200/mcl
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL assessed within seven (7) days prior to the start of therapy
+Absolute neutrophil count >= 1,500 mcl
+Obtained within 28 days prior to registration: Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL; these results must be obtained within 28 days prior to registration
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,000 cells/mcL within 42 days prior to registration
+Absolute neutrophil count (ANC) greater than or equal to 1,500/mcl
+Absolute neutrophil count (ANC) >= 1,500 microliter (mcL) be obtained within 42 days prior to registration
+Absolute granulocyte count > 1,500/mcL
+CLINICAL/LABORATORY CRITERIA: Absolute neutrophil count (ANC) >= 1500/mcL; these results must be obtained within 28 days prior to registration
+Absolute neutrophil count > 500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count > 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcl
+Absolute neutrophil count (ANC) < 1.0 K/mcL at time of enrollment
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) greater than or equal to 1,500/mcl
+Absolute neutrophil count >= 1,500/mcl
+REGISTRATION #2 - PRIOR TO CONSOLIDATION CHEMOTHERAPY: Absolute neutrophil count >= 1,500 mcl
+Absolute neutrophil count (ANC) >= 1,500/mcL obtained within 28 days prior to registration
+Absolute neutrophil count (ANC) >= 1,500/mcl obtained within 28 days prior to RE-TREATMENT registration
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Within 14 days prior to registration: Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Within 56 days prior to randomization: Absolute neutrophil count (ANC) >= 500 cells/mcL (0.5 x 10^9/L); hence ANC must be >= 500/mcL without myeloid growth factor support
+Absolute neutrophil count (ANC) >= 1,000/mcl
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count > 750 cells/mcL (0.75 x 10^9/L)
+Absolute neutrophil count (ANC) >= 1,000/mcl
+Absolute neutrophil count > 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,800/mcL
+Patients must have undergone autologous hematopoietic stem cell transplantation (AHCT) and achieved engraftment by day (D)60-180 as evidenced by absolute neutrophil count (ANC) > 1000/mcL and platelets (Plt) > 75,000/mcL
+ANC > 1000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >=2000 per microliter (/mcL) and platelet count >=100,000/mcL;
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) greater than or equal to 1,500/mcl
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,200/mcL
+Absolute neutrophil count >= 1,500/mcl
+Obtained within 30 days of registration: Absolute neutrophil count >= 1,500/mcL
+Participant has adequate hematological functions [absolute neutrophil count (ANC) ? 1500 cells/microliter (mcL), hemoglobin ? 9 grams/deciliter (g/dL), and platelets ? 100,000 cells/mcL and ? 850,000 cells/mcL]
+Absolute neutrophil count (ANC) >= 1,000 /mcL (performed within 10 days of treatment initiation)
+Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 10 days of treatment initiation
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count > 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL (within 14 days of treatment initiation)
+Absolute neutrophil count >= 1,500/mcL, within 14 days of study registration
+Absolute neutrophil count >= 1000/mcL
+Absolute neutrophil count (ANC) >= 1.5 K/mcL, should be performed within 28 days of treatment initiation, unless otherwise indicated
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count >= 1000/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcl
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,200/mcL
+Absolute neutrophil count >= 1,500/mcL without growth-factor support during the past month
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count > 1,500/mcL
+Absolute neutrophil count >= 1,000/mcl
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcl
+Absolute neutrophil count (ANC) >= 1,500/mcL, performed within 14 days prior to registration
+Within 14 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Performed within 28 days of radiation therapy: Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count (ANC) >= 1000/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcl
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL, performed within 28 days of treatment initiation
+Absolute neutrophil count >= 1,000/mcl
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL (labs should be performed within 14 days of treatment initiation)
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count greater than 1,500/mcL
+Within 14 days of registration: Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+PHASE I: Absolute neutrophil count >= 1,500/mcL
+PHASE II: Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophils count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1.5 K/mcL
+Absolute neutrophil count >= 1,000/mcL in the absence of growth factor administration
+Absolute neutrophil count (ANC) >= 1,500/mcL
+PART B: Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count (ANC) >= 1500/mcl (filgrastim [G-CSF] is allowed) (must be within 7 days of MLA)
+Absolute neutrophil count (ANC) > 1000/mcL
+Absolute neutrophil count (ANC) >= 1.5 K/mcL
+Absolute neutrophil count (ANC) > 1500/mcL
+Absolute neutrophil count > 1,500/mcL
+Absolute neutrophils count >= 1500/mcl
+REGISTRATION INCLUSION CRITERIA: Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,000/mcL
+Absolute neutrophil count >= 1000/microliter (mcL)
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1.5 K/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+absolute neutrophil count >1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,200/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute Neutrophil Count ? 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count > 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute Neutrophil Count (ANC) ? 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) of at least 2000 per mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) count greater than or equal to 1,000/mcL
+Absolute neutrophil count >= 1,000/mcL within two weeks prior to enrollment
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count greater than or equal to 1000/mcl
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count > 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count > 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) < 1000/mcl
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count > 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL*\r\n* Participants may be receiving growth factor support to meet these criteria
+Lymphocyte count >= 300/mcL
+Neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL within 7 days of treatment initiation
+An absolute neutrophil count (ANC) >= 1,500/mcl
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,200/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count > 1,500/mcL
+Absolute neutrophil count (ANC) > 1500/mcl
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcl
+Absolute neutrophil count >= 1,500/mcL
+Performed within 10 days of treatment initiation: Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL (unless due to lymphoma involvement of the bone marrow)
+Absolute neutrophil count > 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcl
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,250/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute lymphocytes > 500/mcL
+Absolute neutrophil count > 1,000/mcL
+Absolute neutrophil count >= 1,500/mcl
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1.5 K/mcL
+Absolute neutrophil count (ANC) >= 1,000/mcL, within 14 days prior to initiation of study drug
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) > 750 cells/mcl
+Absolute neutrophil count >= 1,500/mcL (within four weeks prior to the study)
+Absolute neutrophil count >= 1,500/mcl
+Absolute neutrophil count >= 1,000/mcL independent of growth factor support
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count >= 1,500/mcl
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) greater than or equal to 1,500/mcl
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) < 1.5 K/mcL
+Absolute neutrophil count (ANC) >= 1,000/mcL
+Performed within 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL within 28 days prior to registration
+Absolute neutrophil count > 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL (performed within 10 days of treatment initiation)
+Absolute neutrophil count >= 1,000/mcL
+Absolute lymphocyte count >= 500/mcL
+Obtained within 14 days prior to initiation of treatment: Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count > 1,000/mcL
+Absolute neutrophil count (ANC) >= 500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count >= 1,000/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,000/mcL
+Neutrophil count >= 1000/mcL
+Absolute neutrophil count >= 1,500/mcl
+Absolute neutrophil count > 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 10 days of treatment initiation
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1000/mcL
+Absolute neutrophil count >= 1,000/mcL (measured within 2 weeks of registration)
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) < 1.0 K/mcL
+Absolute neutrophil count >= 1,500/mcL
+At the discretion of the operating surgeon, absolute neutrophil count (ANC) > 1000/mcl
+Absolute neutrophil count (ANC) < 1.0 K/mcL
+At the discretion of the physician, absolute neutrophil count (ANC) > 1000/mcl
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL (within 14 days of study registration)
+Absolute neutrophil count ? 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL, obtained =< 30 days prior to registration
+Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 10 days of treatment initiation
+Absolute neutrophil count (ANC) < 1.0 K/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count ? 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count > 1,500/mcL
+Absolute neutrophil count > 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Hemoglobin must be >=8 gram per deciliter (g/dL), absolute neutrophil count (ANC) must be >=1500 per microliter (/mcL), and platelet count must be >=75,000/mcL.
+Absolute neutrophil count >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL
+Absolute neutrophil count (ANC) >= 1,500/mcL
+Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 10 days of protocol enrollment
+Absolute neutrophil count (ANC) >= 1,500 /mcL